Introduction

Ken Research, a leading market intelligence and consulting firm, partnered with a prominent healthcare provider in India to address the growing need for oncology services in Western Uttar Pradesh. With cancer prevalence on the rise and a lack of accessible, high-quality care facilities in the region, the client sought to establish a world-class oncology hospital that would cater to underserved patients and redefine cancer treatment accessibility.

The client faced several challenges:

1. A growing patient pool of over 60,000 diagnosed cancer cases annually in Western UP but limited infrastructure to cater to them.
2. High referral rates to hospitals in metro cities, with 60% of patients traveling over 200 km for specialized treatments.
3. The need to differentiate in a competitive landscape that included standalone oncology centers and multispecialty hospitals.

Ken Research’s role was to develop a comprehensive solution—from analyzing the market and competitive landscape to creating a robust operational and financial strategy that ensured long-term sustainability.

Challenges and Problem Statement

Cancer care infrastructure in Western Uttar Pradesh lagged behind in critical areas:

• Underserved Patient Population: An estimated 25% of cancer patients in the region delayed or abandoned treatment due to travel-related difficulties.
• Limited Infrastructure: Fewer than 6 dedicated oncology centers served a population of over 80 million, creating significant gaps in service availability.
• Rising Demand: The cancer incidence rate was growing at a 5-year CAGR of 9.5%, with breast, lung, and colorectal cancers being the most prevalent.
• Financial Burden: Over 65% of patients reported out-of-pocket expenditures exceeding ₹2 lakh for advanced treatments, highlighting the lack of affordable care options.

The client’s objectives were clear:

• Expand accessibility: Reduce travel times for underserved populations by building strategically located cancer treatment facilities.
• Enhance quality: Offer cutting-edge treatments such as targeted therapy, PET-CT imaging, and immunotherapy.
• Achieve profitability: Ensure the hospital operates at a sustainable EBITDA margin of 18-20% within five years.

Ken Research’s Approach

Ken Research employed a multi-phased methodology to address the client’s challenges and deliver actionable results. The following sections outline the solutions provided in detail.

1. Strategic Market Assessment

Ken Research conducted a thorough market analysis to identify demand, competitive gaps, and growth opportunities:

• Market Size Estimation:
  • The total oncology services market in Western Uttar Pradesh was valued at ₹4,800 crore in 2023, with an expected growth to ₹8,250 crore by 2028 at a CAGR of 11.5%.
• Demand and Supply Analysis:
  • Identified a patient pool of over 85,000 new cancer cases annually, with a projected treatment rate of 60% by the hospital.
  • Benchmarked 8 competitive facilities, revealing gaps in radiotherapy availability (only 4 centers) and access to specialized pediatric oncology services.
• Key Insights:
  • 35% of demand was concentrated in Tier-2 cities such as Ghaziabad, Agra, and Meerut, while smaller towns like Muzaffarnagar and Modinagar remained underserved.
  • Services like diagnostics and imaging, outpatient chemotherapy, and targeted therapy contributed 40% of patient revenue.

2. Location Strategy and Implementation

Ken Research identified strategic locations for the client’s oncology centers to optimize accessibility and operational efficiency:

• Criteria for Location Selection:
  • Cancer prevalence rates (e.g., 280 cases per 100,000 population in urban clusters).
  • Socioeconomic factors such as average household income of ₹3.5 lakh/year and health insurance penetration of 25%.
  • Competitive saturation and service gaps in cities like Bareilly and Moradabad.
• Proposed Setup:
  • A centralized hub-and-spoke model:
    • Two hubs (Ghaziabad, Agra) offering advanced treatments like PET-CT imaging and surgical oncology.
    • Six satellite centers in Tier-3 cities to provide diagnostics, chemotherapy, and follow-up care.
  • Initial investment of ₹250 crore for land, equipment, and construction.

3. Financial Modeling and Feasibility Analysis

A detailed financial plan ensured the project’s viability:

• Capital Expenditure (CapEx):
  • ₹95 crore for medical equipment, including linear accelerators and robotic surgery systems.
  • ₹60 crore for IT infrastructure and hospital furnishings.
• Operational Expenditure (OpEx):
  • Salaries and wages constituted 45% of OpEx, while consumables like drugs and lab supplies made up 28%.
• Revenue Projections:
  • Year 1: ₹125 crore (60% outpatient services, 30% inpatient, 10% diagnostics).
  • Year 5: ₹320 crore with a 20% EBITDA margin, driven by a steady increase in patient volumes.
• Break-even Point:
  • Achieved in Year 4 with an ROI of 22% by Year 5.

4. Service Differentiation and Patient-Centric Approach

Ken Research identified ways to position the hospital as a leader in cancer care:

• Advanced Treatments: Introduction of precision medicine, targeted therapies, and immunotherapy, expected to attract 20% of patients from neighboring states.
• Patient-Centric Services:
  • Reduced wait times for diagnosis to 48 hours, compared to the market average of 5-7 days.
  • Financial counseling services to help patients access insurance or government health schemes, reducing out-of-pocket expenses by 30%.
• Partnerships:
  • Collaborations with over 40 diagnostic labs and 10 NGOs to expand reach and patient referrals.

5. Building Organizational Excellence

To ensure smooth operations, Ken Research emphasized:

• Staffing and Training:
  • Recruitment of 200+ oncologists, radiologists, and trained nursing staff.
  • Partnership with medical colleges to develop a continuous talent pipeline.
  • Training programs in advanced modalities like robotic surgery, with 80% of staff certified within the first year.
• IT Systems:
  • Integration of AI-driven patient management tools, reducing diagnostic errors by 15%.
  • Telemedicine facilities to extend consultation services to remote areas.

6. Results Achieved

Ken Research’s intervention delivered outstanding results:

1. Patient Reach: Over 50,000 patients treated annually by Year 3, reducing travel distances by 40% for underserved populations.
2. Market Share: Captured 10% of the Western UP oncology services market within 18 months.
3. Operational Excellence: Reduced treatment initiation time by 30%, achieving high patient satisfaction scores (average of 91%).
4. Financial Success: Delivered a sustainable EBITDA margin of 18.5% by Year 3 and projected annual revenues of ₹350 crore by Year 5.

Conclusion

Ken Research’s data-driven approach enabled the healthcare provider to bridge critical gaps in oncology care in Western Uttar Pradesh. By combining rigorous market analysis, financial planning, and operational strategies, the client was able to establish a differentiated oncology service that improved patient outcomes while achieving financial sustainability.

Call to Action

Are you looking to transform your business operations or expand into new markets? Ken Research offers unparalleled expertise in market intelligence and strategy consulting.
Contact us today to explore how we can drive measurable impact for your organization.